Silica glyconanoparticles merge the characteristics of silica with the specific recognition abilities of glycans, presenting a broad spectrum of potential uses. The advancement of silica glyconanoparticles is propelled by the demand for sophisticated materials in diverse fields. In biomedicine, they hold great potential for targeted drug delivery, since the glycan components can interact specifically with cell surface receptors, facilitating the precise delivery of therapeutic substances to diseased cells. Furthermore, their application in biosensing is of significant interest, as they can selectively bind to biomarkers, enabling sensitive and specific detection of diseases. In the domain of materials science, silica glyconanoparticles can be integrated into composites to enhance mechanical and functional attributes. They also demonstrate potential in catalysis, where their surface chemistry can be customized to promote specific reactions.
CD BioGlyco is equipped with an extremely advanced GlycoNano™ Platform and has accumulated rich and profound research experience in the broad and intricate domain of glyconanomics. We are committed to offering a wide and all-encompassing range of glyconanoparticle production services to our esteemed clients. Within this context, we are proficient in fabricating nanoparticles that include but are not restricted to, Carbohydrate-based Nanoparticle, Gold Glyconanoparticle, Silver Glyconanoparticle, Magnetic Glyconanoparticle, Quantum Dot (QD), and silica glyconanoparticles. Our competencies extend to ensuring the accurate synthesis and optimization of these nanoparticles, conforming to the loftiest standards of quality and performance.
During the process of synthesizing particles, several factors affect the size and shape of the particles. We control the size of the example by controlling the regulation of reaction conditions, including reaction temperature, reaction time, reactant concentration, etc. For example, a higher reaction temperature and a longer reaction time may increase the particle size, and a lower reactant concentration may facilitate the formation of smaller particles. At the same time, we control the size and shape of the particles by using templates to limit the growth space of the particles, such as mesoporous materials, polymer microspheres, etc. The selection and concentration of suitable surfactants and their concentration also affect the nucleation and growth process of particles, and different types and concentrations of surfactants have different effects on the size and shape of particles.
We characterize the synthesized nanoparticles by various techniques and methods:
First, we use an improved synthesis method to synthesize fluorescein isothiocyanate (FITC)-silane by reacting FITC with 3-aminopropyl triethoxysilane. Then, our experts prepared mesoporous silicon nanoparticles with uniform and good mesoporous structure by sol-gel method. Subsequently, the synthesized mesoporous silicon nanoparticles are functionalized. The nanoparticles are thiolated with 3-mercaptopropyl trimethoxysilane to form mercaptol particles (FMSNSH). Subsequently, the particles of perfluorophenyl azide (PFPA) group with disulfide bond are further modified with 2-(pyridine-2-yl disulfide) -ethyl 4-fluorobenzoate (FMSNPFPA). Finally, under ultraviolet light, the nanoparticles are glycosylated. Photoinduced azene chemistry is used to convert PFPA azide groups into azene, which then reacts with glycan to obtain silica glyconanoparticle.
Technologies: Confocal fluorescence microscope, TEM
Journal: Chemical Communications
Published: 2015
IF: 4.31
Results: This article focuses on a novel type of glyconanoparticles designed for drug delivery in response to glutathione. The article describes in detail the synthesis of these nanoparticles, including functionalization, drug loading, and closure processes. Specifically, the researchers achieved control of drug release by binding D-mannose-functionalized porous silica nanoparticles to the anti-cancer drug doxorubicin and using the lectin Con A as a “gating” protein. In drug delivery, the role of these sugar nanoparticles is to trigger drug release through the presence of glutathione. The concentration of glutathione is low in healthy cells and high in cancer cells, so this design allows for selective drug release to cancer cells. It has been shown that glutathione can effectively sever the disulfide bonds in the nanoparticles, thereby unsealing Con A and releasing the drug.
Fig.1 Characterization of FMSN- and FMSN-doxorubicin-ConA. (Zhou, et al., 2015)
In terms of biometrics, specific glycan can bind specifically to receptors in organisms (such as proteins and cell surface receptors), giving nanoparticles specific targeted recognition capabilities. Hydrophilic, glycol groups are usually hydrophilic, which improves the dispersion and stability of nanoparticles in aqueous solutions. In terms of immune response regulation, certain glycans can regulate the response of the immune system to nanoparticles, reduce immune rejection, and thus improve biocompatibility.
CD BioGlyco makes use of cutting-edge technologies and methods to ensure that the produced silica glyconanoparticles display outstanding properties and functionality, fulfilling the diverse and specific demands of our clients. In case you require our service, please feel free to contact us!
Reference